Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 24:
Amicus Therapeutics, Inc. FOLD: This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.
Amicus Therapeutics, Inc. price-consensus-chart | Amicus Therapeutics, Inc. Quote
Amicus Therapeutics' shares gained 10.2% over the last three months compared with the S&P 500’s advanced of 6.8%. The company possesses a Momentum Score of A.
Amicus Therapeutics, Inc. price | Amicus Therapeutics, Inc. Quote
Clipper Realty Inc. CLPR: This real estate company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.6% over the last 60 days.
Clipper Realty Inc. price-consensus-chart | Clipper Realty Inc. Quote
Clipper Realty's shares gained 68.2% over the last three months compared with the S&P 500’s advanced of 6.7%. The company possesses a Momentum Score of B.
Clipper Realty Inc. price | Clipper Realty Inc. Quote
Harrow, Inc. HROW: This eyecare pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 164.3% over the last 60 days.
Harrow, Inc. price-consensus-chart | Harrow, Inc. Quote
Harrow's shares gained 127.2% over the last three months compared with the S&P 500’s advanced of 6.7%. The company possesses a Momentum Score of A.
Harrow, Inc. price | Harrow, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amicus Therapeutics, Inc. (FOLD) : Free Stock Analysis Report
Clipper Realty Inc. (CLPR) : Free Stock Analysis Report
Harrow, Inc. (HROW) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。